CSF neurofilament proteins in the differential diagnosis of dementia
Open accessAbstract
BACKGROUND: Neurofilament (NF) proteins are major cytoskeletal constituents of neurons. Increased CSF NF levels may reflect neuronal degeneration. OBJECTIVE: To investigate the diagnostic value of CSF NF analysis to discriminate in relatively young dementia patients between frontotemporal lobe degeneration (FTLD) and early onset Alzheimer's disease (EAD; onset < or = 65 years of age), and in elderly dementia patients between dementia with Lewy bodies (DLB) and late onset AD (LAD; onset > 65 years of age). METHODS: In CSF of 28 FTLD, 37 EAD, 18 DLB and 33 LAD patients, and 26 control subjects, we analysed NF light chain (NFL), phosphorylated NF heavy chain (pNFH), amyloid beta42 protein (Abeta42), total tau and tau phosphorylated at threonine 181 (p-tau181). RESULTS: CSF NFL levels were higher in FTLD patients compared with EAD patients (p<0.001), and diagnostic accuracy of p-tau181 and Abeta42 analysis improved with addition of NFL analysis (sensitivity 86%, specificity 100%). CSF pNFH levels were elevated in DLB, LAD and FTLD compared with controls (p<0.05) but no significant differences were found between the dementia groups. CONCLUSIONS: In the diagnostic workup of relatively young dementia patients, CSF NFL levels may play a role in the discrimination between FTLD and EAD, especially in combination with Abeta42 and p-tau181 analysis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Combination of AD CSF biomarkers (Aβ42 and p-tau181) with CSF NfL could discriminate FTLD from AD with high performance (AUC > 0.90).
“For instance, combination of AD CSF biomarkers (Aβ42 and p‐tau181) with CSF NfL could discriminate FTLD from AD with high performance (AUC > 0.90).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. L., & Stadlan, E. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 9,882 · see citing works
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047 · see citing works
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works
Weıntraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 3,012 · see citing works
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
Petzold, A. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.015 · Cited by 688 · see citing works
McKeith, I. G. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s347 · Cited by 625 · see citing works
Rosengren, L. E., Karlsson, J., Karlsson, J., Persson, L. I., & Wikkelsø, C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052013.x · Cited by 499 · see citing works
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Faber, R., & Neary, D. (1999) · Neurology · doi:10.1212/wnl.53.5.1158-b · Cited by 371 · see citing works
Elevated neurofilament levels in neurological diseases
Norgren, N., Rosengren, L., & Stigbrand, T. I. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03219-0 · Cited by 351 · see citing works
Neurofilament protein in cerebrospinal fluid: A marker of white matter changes
Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. ‐., Edman, Å., Lind, K., Rosengren, L., Blennow, K., & Wallin, A. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1242 · Cited by 209 · see citing works
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
Sjögren, M., Rosengren, L., Minthon, L., Davidsson, P., Blennow, K., & Wallin, A. (2000) · Neurology · doi:10.1212/wnl.54.10.1960 · Cited by 181 · see citing works
The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs
Burns, J. M., Galvin, J. E., Roe, C. M., Morris, J. C., & McKeel, D. W. (2005) · Neurology · doi:10.1212/01.wnl.0000158423.05224.7f · Cited by 175 · see citing works
A specific ELISA for measuring neurofilament heavy chain phosphoforms
Petzold, A., Keir, G., Green, A. J. E., Giovannoni, G., & Thompson, E. J. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00189-3 · Cited by 158 · see citing works
Neurofilament protein levels in CSF are increased in dementia
Rosengren, L., Karlsson, J. E., Sjögren, M. J. C., Blennow, K., & Wallin, A. (1999) · Neurology · doi:10.1212/wnl.52.5.1090 · Cited by 154 · see citing works
Hu, Y., Shanshu, H., Wang, X., Duan, Q., Khatoon, S., Iqbal, K., Grundke, I., & Wang, J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00047-2 · Cited by 106 · see citing works
de Jong, D., Jansen, R. W. M. M., Kremer, B. P. H., & Verbeek, M. M. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.7.755 · Cited by 98 · see citing works
Self-citationPresenile dementia syndromes: an update on taxonomy and diagnosis
Greicius, M. D. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.691 · Cited by 85 · see citing works
An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid
van Geel, W. J. A., Rosengren, L., & Verbeek, M. M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.11.015 · Cited by 82 · see citing works
Self-citationDifferent variants of frontotemporal dementia: a neuropathological and immunohistochemical study
Bergmann, M., Kuchelmeister, K., Schmid, K. W., Kretzschmar, H. A., & Schröder, R. (1996) · Acta Neuropathologica · doi:10.1007/s004010050505 · Cited by 78 · see citing works
The Neurofilament Heavy Chain (NfHSMI35) in the Cerebrospinal Fluid Diagnosis of Alzheimer’s Disease
Brettschneider, J., Petzold, A., Schöttle, D., Claus, A., Riepe, M. W., & Tumani, H. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000091436 · Cited by 69 · see citing works
CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia
Abdo, W. F., van de Warrenburg, B. P. C., Munneke, M. A. M., van Geel, W. J. A., Bloem, B. R., Kremer, H., & Verbeek, M. M. (2006) · Neurology · doi:10.1212/01.wnl.0000227891.25592.8c · Cited by 52 · see citing works
Self-citationNeurofilament-Immunoreactive Neurons in Alzheimer's Disease and Dementia with Lewy Bodies
Shepherd, C. E., McCann, H., Thiel, E., & Halliday, G. M. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0469 · Cited by 47 · see citing works
Sjögren, M. J. C., & Wallin, A. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00303-7 · Cited by 30 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · see citing works
Neurofilament light chain as a biomarker in neurological disorders
Gaetani, L., Blennow, K., Calabresi, P., Di Filippo, M., Parnetti, L., & Zetterberg, H. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320106 · Cited by 1,334 · see citing works
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
Rohrer, J. D., Woollacott, I., Dick, K. M., Brotherhood, E., Gordón, E., Fellows, A. D., Toombs, J., Druyeh, R., Cardoso, M. J., Sebastien Ourselin, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003154 · Cited by 431 · see citing works
Biochemistry of Tau in Alzheimer’s disease and related neurological disorders
Sergeant, N., Bretteville, A., Hamdane, M., Caillet-Boudin, M.-L., Grognet, P., Bombois, S., Blum, D., Delacourte, A., Pasquier, F., Vanmechelen, E., et al. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.207 · Cited by 300 · see citing works
Lewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramı́rez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 308 · see citing works
Self-citationCerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Mattsson, N., Insel, P. S., Palmqvist, S., Portelius, E., Zetterberg, H., Weiner, M. W., Blennow, K., Hansson, O., & Initiative, T. A. D. N. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606540 · Cited by 293 · see citing works
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
Yuan, A., & Nixon, R. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.689938 · Cited by 290 · see citing works
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001015 · Cited by 263 · see citing works
Molecular biomarkers of Alzheimer's disease: progress and prospects
Lashley, T., Schott, J. M., Weston, P. S. J., Murray, C. E., Wellington, H., Keshavan, A., Foti, S. C., Foiani, M. S., Toombs, J., Rohrer, J. D., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031781 · Cited by 233 · see citing works
Forgrave, L. M., Ma, M., Best, J. R., & DeMarco, M. L. (2019) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.08.009 · Cited by 177 · see citing works
Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
van Harten, A. C., Kester, M. I., Visser, P. J., Blankenstein, M. A., Pijnenburg, Y. A. L., van der Flier, W. M., & Scheltens, P. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.086 · Cited by 164 · see citing works
Self-citationNeurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Verde, F., Otto, M., & Silani, V. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.679199 · Cited by 152 · see citing works
Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Mahaman, Y. A. R., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J.-Z., Liu, R., Feng, J., & Wang, X. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101544 · Cited by 149 · see citing works
Tortelli, R., Ruggieri, M., Cortese, R., D’Errico, E., Capozzo, R., Leo, A., Mastrapasqua, M., Zoccolella, S., Leante, R., Livrea, P., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03777.x · Cited by 151 · see citing works
Alirezaei, Z., Pourhanifeh, M. H., Borran, S., Nejati, M., Mirzaei, H., & Hamblin, M. R. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01698-3 · Cited by 142 · see citing works
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
Landqvist Waldö, M., Frizell Santillo, A., Passant, U., Zetterberg, H., Rosengren, L., Nilsson, C., & Englund, E. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-54 · Cited by 127 · see citing works
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122 · see citing works
Frontotemporal Dementia, Where Do We Stand? A Narrative Review
Antonioni, A., Raho, E. M., Lopriore, P., Pace, A. P., Latino, R. R., Assogna, M., Mancuso, M., Gragnaniello, D., Granieri, E., Pugliatti, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411732 · Cited by 133 · see citing works
Dhiman, K., Blennow, K., Zetterberg, H., Martins, R. N., & Gupta, V. B. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03040-5 · Cited by 114 · see citing works
Rojas, J. C., Wang, P., Staffaroni, A. M., Heller, C., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Ljubenkov, P. A., Heuer, H. W., Fong, J. C., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011848 · Cited by 106 · see citing works
Jin, M., Cao, L., & Dai, Y. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00254 · Cited by 105 · see citing works
Zhao, Y., Xin, Y., Meng, S., He, Z., & Hu, W. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.014 · Cited by 105 · see citing works
Dhiman, K., Gupta, V. B., Villemagne, V. L., Eratne, D., Graham, P. L., Fowler, C., Bourgeat, P., Li, Q., Collins, S., Bush, A. I., et al. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12005 · Cited by 93 · see citing works
Irwin, D. J., Trojanowski, J. Q., & Grossman, M. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00006 · Cited by 96 · see citing works
Aluise, C. D., Robinson, R. A. S., & Butterfield, D. A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.07.008 · Cited by 92 · see citing works
Zerr, I., Schmitz, M., Karch, A., Villar‐Piqué, A., Kanata, Ε., Golańska, E., Lucena, D. D., Karsanidou, A., Hermann, P., Knipper, T., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.12.008 · Cited by 87 · see citing works
Neurofilaments in disease: what do we know?
Gordon, B. A. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.02.001 · Cited by 82 · see citing works
EFNS guidelines on disease‐specific CSF investigations
Deisenhammer, F., Egg, R., Giovannoni, G., Hemmer, B., Petzold, A., Sellebjerg, F., Teunissen, C., & Tumani, H. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02595.x · Cited by 86 · see citing works
Younes, K., & Miller, B. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.006 · Cited by 74 · see citing works
Biological fluid biomarkers in neurodegenerative parkinsonism
Eller, M., & Williams, D. R. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.135 · Cited by 71 · see citing works
Jellinger, K. A., Janetzky, B., Attems, J., & Kienzl, E. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00313.x · Cited by 70 · see citing works
Chhatwal, J. P., Schultz, A. P., Dang, Y., Ostaszewski, B., Liu, L., Yang, H.-S., Johnson, K. A., Sperling, R. A., & Selkoe, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-19543-w · Cited by 60 · see citing works
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
Baldacci, F., Mazzucchi, S., Vecchia, A. D., Giampietri, L., Giannini, N., Koronyo‐Hamaoui, M., Ceravolo, R., Siciliano, G., Bonuccelli, U., Elahi, F. M., et al. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1731306 · Cited by 64 · see citing works
Applying fluid biomarkers to Alzheimer's disease
Zetterberg, H. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00007.2017 · Cited by 62 · see citing works
Biomarkers for diseases with TDP-43 pathology
Steinacker, P., Barschke, P., & Otto, M. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.10.003 · Cited by 57 · see citing works
Goossens, J., Bjerke, M., Mossevelde, S. V., den Bossche, T. V., Goeman, J., Vil, B. B. D., Sieben, A., Martin, J., Cras, P. P., Deyn, P. P. D., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0364-0 · Cited by 56 · see citing works
Su, W., Chen, H. B., Li, S. H., & Wu, D. Y. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.11.002 · Cited by 57 · see citing works
Zanier, E. R., Refai, D., Zipfel, G. J., Zoerle, T., Longhi, L. G., Esparza, T. J., Spinner, M. L., Bateman, R. J., Brody, D. L., & Stocchetti, N. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.177667 · Cited by 57 · see citing works
Fialová, L., Bartoš, A., Švarcová, J., Zimová, D., Kotoucova, J., & Malbohan, I. M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.06.010 · Cited by 56 · see citing works
Rivero‐Santana, A., Ferreira, D., Perestelo‐Pérez, L., Westman, E., Wahlund, L., Sarría‐Santamera, A., & Serrano-Aguilar, P. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160366 · Cited by 56 · see citing works
The role of neurofilament light chain in frontotemporal dementia: a meta-analysis
Karantali, E., Kazis, D. A., Chatzikonstantinou, S., Petridis, F., & Mavroudis, I. A. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01554-8 · Cited by 54 · see citing works
Lu, C., Petzold, A., Kalmár, B., Dick, J. R. T., Malaspina, A., & Greensmith, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040998 · Cited by 55 · see citing works
Is there a CSF biomarker profile related to depression in elderly women?
Gudmundsson, P., Skoog, I. G., Wærn, M., Blennow, K., Zetterberg, H., Rosengren, L., & Gustafson, D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.11.012 · Cited by 55 · see citing works
del Campo, M., Zetterberg, H., Gandy, S., Onyike, C. U., Oliveira, F., Udeh‐Momoh, C., Lleó, A., Teunissen, C. E., & Pijnenburg, Y. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12643 · Cited by 52 · see citing works
Self-citationReview: Fluid biomarkers for frontotemporal dementias
Zetterberg, H., van Swieten, J. C., Boxer, A. L., & Rohrer, J. D. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12530 · Cited by 48 · see citing works
Skillbäck, T. B., Zetterberg, H., Blennow, K., & Mattsson, N. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt212 · Cited by 48 · see citing works
Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
Leko, M. B., Štrac, D. Š., Mück‐Šeler, D., Pivac, N., Stanić, G., Hof, P. R., & Šimić, G. (2014) · Croatian Medical Journal · doi:10.3325/cmj.2014.55.347 · Cited by 46 · see citing works
Neurochemical biomarkers in the differential diagnosis of movement disorders
Mollenhauer, B., & Trenkwalder, C. (2009) · Movement Disorders · doi:10.1002/mds.22510 · Cited by 45 · see citing works
CSF Neurofilament Proteins Levels are Elevated in Sporadic Creutzfeldt-Jakob Disease
van Eijk, J. J. J., Everbroeck, B. V., Abdo, W. F., Kremer, B. P. H., & Verbeek, M. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-090649 · Cited by 41 · see citing works
Self-citationBruno, D., Pomara, N., Nierenberg, J. J., Ritchie, J., Lutz, M. W., Zetterberg, H., & Blennow, K. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.09.008 · Cited by 39 · see citing works
Menculini, G., Chipi, E., Paoletti, F. P., Gaetani, L., Nigro, P., Simoni, S., Mancini, A., Tambasco, N., Filippo, M. D., Tortorella, A. A. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094440 · Cited by 42 · see citing works
Wang, Z., Wang, R., Li, Y., Li, M., Zhang, Y., Jiang, L., Fan, J., Wang, Q., & Yang, D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631738 · Cited by 39 · see citing works
Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
Mukaetova‐Ladinska, E. B., Monteith, R., & Perry, E. K. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/536538 · Cited by 37 · see citing works
Neurofilaments contribution in clinic: state of the art
Delaby, C., Bousiges, O., Bouvier, D., Fillée, C., Fourier, A., Mondésert, E., Nezry, N., Omar, S., Quadrio, I., Rucheton, B., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1034684 · Cited by 38 · see citing works
Cousins, K. A. Q., Phillips, J. S., Irwin, D. J., Lee, E. B., Wolk, D. A., Shaw, L. M. J., Zetterberg, H., Blennow, K., Burke, S., Kinney, N. G., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12233 · Cited by 36 · see citing works
Biomarkers in biological fluids for dementia with Lewy bodies
Schade, S., & Mollenhauer, B. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0072-3 · Cited by 36 · see citing works
Blood Biomarkers for Alzheimer’s Disease: Much Promise, Cautious Progress
Keshavan, A., Heslegrave, A., Zetterberg, H., & Schott, J. M. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0241-0 · Cited by 34 · see citing works
Hildebrandt, H., Haldenwanger, A., & Eling, P. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0931 · Cited by 32 · see citing works
Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update
Oeckl, P., Steinacker, P., Feneberg, E., & Otto, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13669 · Cited by 30 · see citing works
Recent advances in understanding frontotemporal degeneration
Borroni, B., & Benussi, A. (2019) · F1000Research · doi:10.12688/f1000research.20330.1 · Cited by 30 · see citing works
Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study
Vrillon, A., Ashton, N. J., Karikari, T. K., Götze, K., Cognat, E., Dumurgier, J., Lilamand, M., Zetterberg, H., Blennow, K., & Paquet, C. (2024) · Journal of Neurology · doi:10.1007/s00415-023-12066-6 · Cited by 28 · see citing works
Oeckl, P., Steinacker, P., Feneberg, E., & Otto, M. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.12.010 · Cited by 27 · see citing works
Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
Prete, E. D., Beatino, M. F., Campese, N., Giampietri, L., Siciliano, G., Ceravolo, R., & Baldacci, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040221 · Cited by 27 · see citing works
Duran-Aniotz, C. A., Orellana, P., Rodríguez, T. L., Henríquez, F., Cabello, V., Aguirre-Pinto, M. F., Escobedo, T., Takada, L. T., Piña‐Escudero, S. D., López, O. L., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.663407 · Cited by 26 · see citing works
Brain perfusion SPECT correlates with CSF biomarkers in Alzheimer’s disease
Habert, M., de Souza, L. C., Lamari, F., Daragon, N., Désarnaud, S., Jardel, C., Dubois, B., & Sarazin, M. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1285-8 · Cited by 25 · see citing works
Zetterberg, H., Lautner, R., Skillbäck, T. B., Rosén, C., Shahim, P., Mattsson, N., & Blennow, K. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800141-7.00005-x · Cited by 21 · see citing works
Brinkmalm, A., Portelius, E., Brinkmalm, G., Pannee, J., Dahlén, R., Gobom, J., Blennow, K., & Zetterberg, H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14594 · Cited by 21 · see citing works
Kou, W., Li, S., Yan, R., Zhang, J., Wan, Z., & Feng, T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13051-x · Cited by 22 · see citing works
Frontotemporal dementia. How to deal with its diagnostic complexity?
Antonioni, A., Raho, E. M., Granieri, E., & Koch, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2461758 · Cited by 21 · see citing works
Han, T., Cong, H., Yu, B., & Shen, Y. (2022) · BioFactors · doi:10.1002/biof.1875 · Cited by 18 · see citing works
Liu, H.-C., Lin, W., Chiu, M., Lu, C.-H., Lin, C.-Y., & Yang, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234519 · Cited by 18 · see citing works
The Alzheimer's Disease Neuroimaging Initiative Neuropathology Core: An update
Perrin, R. J., Franklin, E. E., Bernhardt, H., Burns, A., Schwetye, K. E., Cairns, N. J., Baxter, M., Weiner, M. W., Morris, J. C., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14253 · Cited by 17 · see citing works
Emerging Biomarkers in Cognition
Wicklund, M. R., & Petersen, R. C. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.006 · Cited by 17 · see citing works
Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia
Álvarez, I., Díez-Fairén, M., Aguilar, M., González, J. M., Ysamat, M., Tartari, J. P., Cárcel, M., Alonso, Á., Brix, B., Arendt, P., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14658 · Cited by 17 · see citing works
Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers
Katisko, K., Cajanus, A., Korhonen, T., Remes, A. M., Haapasalo, A., & Solje, E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00658 · Cited by 16 · see citing works
Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation
Fialová, L., Bartoš, A., & Švarcová, J. (2017) · Biomedical Papers · doi:10.5507/bp.2017.038 · Cited by 15 · see citing works
Serum peptides as candidate biomarkers for dementia with Lewy bodies
Suzuki, I., Noguchi, M., Arito, M., Sato, T., Omoteyama, K., Maedomari, M., Hasegawa, H., Suematsu, N., Okamoto, K., Kato, T., et al. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4274 · Cited by 14 · see citing works
Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
Zetterberg, H., Mattsson, N., & Blennow, K. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/163065 · Cited by 14 · see citing works
CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers
Rostgaard, N., Roos, P., Portelius, E., Blennow, K., Zetterberg, H., Simonsen, A. H., & Nielsen, J. E. (2017) · Neurology · doi:10.1212/wnl.0000000000004799 · Cited by 13 · see citing works
Wu, C., Pan, X.-S., Su, L.-Y., & Yang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813771 · Cited by 12 · see citing works
Cerebrospinal fluid in the dementias
Zetterberg, H., Rohrer, J. D., & Schott, J. M. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00006-x · Cited by 12 · see citing works
Saunders, T. S., Gadd, D. A., Spires‐Jones, T. L., King, D., Ritchie, C. W., & Terrera, G. M. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15656 · Cited by 12 · see citing works
Fluid Biomarkers of Frontotemporal Lobar Degeneration
van der Ende, E. L., & Swieten, J. C. V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_9 · Cited by 10 · see citing works
Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis
Mishima, A., Nihashi, T., Ando, Y., Kawai, H., Kato, T., Ito, K., & Terasawa, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150675 · Cited by 10 · see citing works
Bridging Molecular Genetics and Biomarkers in Lewy Body and Related Disorders
Ho, G., Liang, W., Waragai, M., Sekiyama, K., Masliah, E., & Hashimoto, M. (2011) · International Journal of Alzheimer's Disease · doi:10.4061/2011/842475 · Cited by 10 · see citing works
Biofluid biomarkers for Alzheimer’s disease
Wang, S., Xie, S., Zheng, Q., Zhang, Z., Wang, T., & Zhang, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1380237 · Cited by 8 · see citing works
CSF tau proteins in differential diagnosis of dementia
Boban, M., Šarac, H., Mimica, N., Mladinov, M., Süßmair, C., Ackl, N., Bader, B., Huzak, M., Danek, A., Hof, P. R., et al. (2010) · Translational Neuroscience · doi:10.2478/v10134-010-0013-z · Cited by 8 · see citing works
Kühle, J., & Petzold, A. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.592184 · Cited by 8 · see citing works
Kaur, G., Poljak, A., Braidy, N., Crawford, J. D., Lo, J., & Sachdev, P. S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200052 · Cited by 8 · see citing works
Neurofilament heavy phosphorylated epitopes as biomarkers in ageing and neurodegenerative disease
Paoli, L. F. D., Kirkcaldie, M., King, A. E., & Collins, J. M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16261 · Cited by 7 · see citing works
Olofsson, J., Bergström, S., Mravinacová, S., Kläppe, U., Öijerstedt, L., Zetterberg, H., Blennow, K., Ingre, C., Nilsson, P., & Månberg, A. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2428930 · Cited by 6 · see citing works
Walia, N., Eratne, D., Loi, S. M., Li, Q.-X., Varghese, S., Malpas, C. B., Walterfang, M., Evans, A. H., Parker, S., Collins, S. J., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120088 · Cited by 6 · see citing works
Olsson, B., Schott, J. M., Blennow, K., & Zetterberg, H. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1341311 · Cited by 6 · see citing works
Alberti, C., Gonzalez, J., Maldonado, H., Medina, F., Barriga, A., Garcı́a, L., Kettlun, A. M., Collados, L., Puente, J., Cartier, L., et al. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0262 · Cited by 6 · see citing works
Clinical Use of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
Zetterberg, H., Lunn, M. P., & Herukka, S. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.47 · Cited by 5 · see citing works
Biomarkører i spinalvæske ved demens
Skogseth, R. E., Fladby, T., Mulugeta, E., & Aarsland, D. (2011) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.10.0104 · Cited by 5 · see citing works
Serum neurofilament heavy chain predicts post-stroke cognitive impairment
Qiao, H., Wang, S., Tao, M., Fan, H., Zhao, T., Du, Y., & Dong, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-96952-1 · Cited by 4 · see citing works
Systematic review of differentially abundant proteins in people with Lewy body dementia
Farr, L. M., Thorpe, N., Brinda, E. M., Al‐Balushi, N., Sohail, M., & Rajkumar, A. P. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2025.15 · Cited by 5 · see citing works
Dutysheva, E. A., Викторовна, З. А., Valko, M. A., Antipina, E. O., Zimatkin, S. M., Margulis, B. A., Guzhova, I. V., & Lazarev, V. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311541 · Cited by 3 · see citing works
Feneberg, E., Steinacker, P., Lehnert, S., Neumann, M., & Otto, M. (2012) · Journal of Laboratory Medicine · doi:10.1515/jlm-2011-0009 · Cited by 3 · see citing works
- Authors
- de Jong, D., Jansen, R. W. M. M., Pijnenburg, Y. A. L., van Geel, W. J. A., Borm, G. F., Kremer, H. P. H., & Verbeek, M. M.
- Affiliations
- Radboud University Medical Center (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Verbeek, M M
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2007-09-01
- Volume
- 78
- Issue
- 9
- Pages
- 936-938
- ISSN
- 0022-3050 (ISSN-L)
- PMC
- PMC2117885
- OpenAlex
- W2004037240
- Cited by
- 120
- References
- 25
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 10 · 2020: 13 · 2019: 9 · 2018: 7 · 2017: 6 · 2016: 7 · 2015: 4 · 2014: 5 · 2013: 7 · 2012: 7
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- American Health Assistance Foundation
- Hersenstichting
- Alzheimer Nederland
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- neurofilament light chain, cerebrospinal fluid biomarkers, differential diagnosis of dementia, frontotemporal lobar degeneration, early-onset Alzheimer's disease, dementia with Lewy bodies, late-onset Alzheimer's disease, amyloid-beta 42, tau phosphorylation, p-tau181, neurodegeneration
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Alzheimer Disease, Dementia, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Case-Control Studies, Amyloid beta-Peptides, tau Proteins, Neurofilament Proteins, Lewy Body Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
